CY1108452T1 - ΠΑΡΑΓΩΓΑ ΙΜΙΔΑΖΟΛΙΟΥ ΚΑΙ ΧΡΗΣΗ ΑΥΤΩΝ ΩΣ ΠΕΡΙΦΕΡΙΚΩΣ ΕΚΛΕΚΤΙΚΩΝ ΑΝΑΣΤΟΛΕΩΝ ΤΗΣ ΝΤΟΠΑΜΙΝΗΣ-β-ΥΔΡΟΞΥΛΑΣΗΣ - Google Patents
ΠΑΡΑΓΩΓΑ ΙΜΙΔΑΖΟΛΙΟΥ ΚΑΙ ΧΡΗΣΗ ΑΥΤΩΝ ΩΣ ΠΕΡΙΦΕΡΙΚΩΣ ΕΚΛΕΚΤΙΚΩΝ ΑΝΑΣΤΟΛΕΩΝ ΤΗΣ ΝΤΟΠΑΜΙΝΗΣ-β-ΥΔΡΟΞΥΛΑΣΗΣInfo
- Publication number
- CY1108452T1 CY1108452T1 CY20081101204T CY081101204T CY1108452T1 CY 1108452 T1 CY1108452 T1 CY 1108452T1 CY 20081101204 T CY20081101204 T CY 20081101204T CY 081101204 T CY081101204 T CY 081101204T CY 1108452 T1 CY1108452 T1 CY 1108452T1
- Authority
- CY
- Cyprus
- Prior art keywords
- hydroxylum
- dopopamin
- imidazoli
- extractive
- inhibitors
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010007558 Cardiac failure chronic Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0223719A GB2393958A (en) | 2002-10-11 | 2002-10-11 | Peripherally-selective imidazole inhibitors of dopamine-beta-hydroxylase |
GB0224306A GB2394223B (en) | 2002-10-11 | 2002-10-18 | Peripherally-selective inhibitors of dopamine-beta-hydroxylase and method of their preparation |
EP03256420A EP1408038B1 (de) | 2002-10-11 | 2003-10-10 | Imidazolderivate und deren Verwendung als peripheral-selektive Inhibitoren von Dopamin-beta-Hydroxylasen |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1108452T1 true CY1108452T1 (el) | 2014-04-09 |
Family
ID=9945777
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081101204T CY1108452T1 (el) | 2002-10-11 | 2008-10-24 | ΠΑΡΑΓΩΓΑ ΙΜΙΔΑΖΟΛΙΟΥ ΚΑΙ ΧΡΗΣΗ ΑΥΤΩΝ ΩΣ ΠΕΡΙΦΕΡΙΚΩΣ ΕΚΛΕΚΤΙΚΩΝ ΑΝΑΣΤΟΛΕΩΝ ΤΗΣ ΝΤΟΠΑΜΙΝΗΣ-β-ΥΔΡΟΞΥΛΑΣΗΣ |
CY20111100639T CY1112457T1 (el) | 2002-10-11 | 2011-07-01 | Χρωμανο- και θειοxρωμανο-3-υλο-1,3-διυδρο-ιμιδαζολια ως αναστολεις της ντοπαμινο-β-υδροξυλασης, και μεθοδοι παρασκευης αυτων |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20111100639T CY1112457T1 (el) | 2002-10-11 | 2011-07-01 | Χρωμανο- και θειοxρωμανο-3-υλο-1,3-διυδρο-ιμιδαζολια ως αναστολεις της ντοπαμινο-β-υδροξυλασης, και μεθοδοι παρασκευης αυτων |
Country Status (11)
Country | Link |
---|---|
KR (1) | KR101350741B1 (de) |
CN (1) | CN100393715C (de) |
AR (2) | AR041589A1 (de) |
AT (5) | ATE505465T1 (de) |
CY (2) | CY1108452T1 (de) |
DE (4) | DE60336276D1 (de) |
DK (2) | DK1908760T3 (de) |
ES (5) | ES2309279T3 (de) |
GB (2) | GB2393958A (de) |
HK (1) | HK1116188A1 (de) |
SI (2) | SI1908760T1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0708818D0 (en) * | 2007-05-08 | 2007-06-13 | Portela & Ca Sa | Compounds |
BR112013015864B1 (pt) * | 2010-12-22 | 2021-11-09 | Bial - Portela & C.A., S.A. | Processo para purificar um composto de forma cristalina a de (r)-5-(2-benzilamino)etil)-1- (6,8-difluorocroman-3-il)-1h-imidazol-2(3h)-tiona |
GB201316410D0 (en) * | 2013-09-13 | 2013-10-30 | Bial Portela & Ca Sa | Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2581556B2 (ja) * | 1986-05-06 | 1997-02-12 | メレルダウファーマスーティカルズ インコーポレーテッド | 新規なドパミンベ−タヒドロキシラ−ゼ抑制剤 |
US4868210A (en) | 1988-03-30 | 1989-09-19 | Warner-Lambert Company | Antihyperlipidemic and antiatherosclerotic compounds and compositions |
WO1995029165A2 (en) * | 1994-04-26 | 1995-11-02 | Syntex (U.S.A.) Inc. | Benzocycloalkylaz0lethione derivatives as dopamin beta-hydroxylase inhibitors |
-
2002
- 2002-10-11 GB GB0223719A patent/GB2393958A/en not_active Withdrawn
- 2002-10-18 GB GB0224306A patent/GB2394223B/en not_active Expired - Lifetime
-
2003
- 2003-10-10 DE DE60336276T patent/DE60336276D1/de not_active Expired - Lifetime
- 2003-10-10 SI SI200331986T patent/SI1908760T1/sl unknown
- 2003-10-10 DK DK07076125.9T patent/DK1908760T3/da active
- 2003-10-10 AT AT07076125T patent/ATE505465T1/de active
- 2003-10-10 AT AT07076122T patent/ATE500248T1/de not_active IP Right Cessation
- 2003-10-10 ES ES03256420T patent/ES2309279T3/es not_active Expired - Lifetime
- 2003-10-10 DE DE60336772T patent/DE60336772D1/de not_active Expired - Lifetime
- 2003-10-10 DK DK03256420T patent/DK1408038T3/da active
- 2003-10-10 AR ARP030103711A patent/AR041589A1/es active IP Right Grant
- 2003-10-10 SI SI200331309T patent/SI1408038T1/sl unknown
- 2003-10-10 ES ES07076123T patent/ES2384118T3/es not_active Expired - Lifetime
- 2003-10-10 ES ES07076124T patent/ES2361939T3/es not_active Expired - Lifetime
- 2003-10-10 DE DE60336275T patent/DE60336275D1/de not_active Expired - Lifetime
- 2003-10-10 AT AT07076123T patent/ATE550335T1/de active
- 2003-10-10 DE DE60322642T patent/DE60322642D1/de not_active Expired - Lifetime
- 2003-10-10 KR KR1020127005102A patent/KR101350741B1/ko active IP Right Grant
- 2003-10-10 AT AT07076124T patent/ATE500247T1/de not_active IP Right Cessation
- 2003-10-10 CN CNB2003801059426A patent/CN100393715C/zh not_active Expired - Fee Related
- 2003-10-10 AT AT03256420T patent/ATE403652T1/de active
- 2003-10-10 ES ES07076125T patent/ES2364919T3/es not_active Expired - Lifetime
- 2003-10-10 ES ES07076122T patent/ES2361938T3/es not_active Expired - Lifetime
-
2008
- 2008-10-09 HK HK08111214.9A patent/HK1116188A1/xx not_active IP Right Cessation
- 2008-10-24 CY CY20081101204T patent/CY1108452T1/el unknown
-
2011
- 2011-07-01 CY CY20111100639T patent/CY1112457T1/el unknown
-
2014
- 2014-03-18 AR ARP140101283A patent/AR095674A2/es unknown
Also Published As
Publication number | Publication date |
---|---|
ATE500247T1 (de) | 2011-03-15 |
GB0224306D0 (en) | 2002-11-27 |
ATE500248T1 (de) | 2011-03-15 |
ES2364919T3 (es) | 2011-09-16 |
SI1408038T1 (sl) | 2008-10-31 |
ES2361939T3 (es) | 2011-06-24 |
DK1908760T3 (da) | 2011-07-25 |
DE60336276D1 (de) | 2011-04-14 |
ATE505465T1 (de) | 2011-04-15 |
GB2393958A (en) | 2004-04-14 |
DK1408038T3 (da) | 2008-11-24 |
KR20120038014A (ko) | 2012-04-20 |
GB2394223B (en) | 2007-05-16 |
AR041589A1 (es) | 2005-05-26 |
CN1726211A (zh) | 2006-01-25 |
ES2361938T3 (es) | 2011-06-24 |
AR095674A2 (es) | 2015-11-04 |
GB0223719D0 (en) | 2002-11-20 |
HK1116188A1 (en) | 2008-12-19 |
KR101350741B1 (ko) | 2014-01-10 |
DE60322642D1 (de) | 2008-09-18 |
ES2384118T3 (es) | 2012-06-29 |
CN100393715C (zh) | 2008-06-11 |
GB2394223A (en) | 2004-04-21 |
DE60336772D1 (de) | 2011-05-26 |
ES2309279T3 (es) | 2008-12-16 |
DE60336275D1 (de) | 2011-04-14 |
ATE550335T1 (de) | 2012-04-15 |
CY1112457T1 (el) | 2015-12-09 |
ATE403652T1 (de) | 2008-08-15 |
SI1908760T1 (sl) | 2011-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108041T1 (el) | Αναστολεις της rho-κινασης | |
CY1117217T1 (el) | Συνθεση και αντι-ιικη δραστηριοτητα των υποκατεστημενων παραγωγων αζαϊνδολοοξοοξικης πιπεραζινης | |
EA200300717A1 (ru) | Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов | |
CY1107475T1 (el) | Αναστολεις ρο-κινασης | |
EA200401398A1 (ru) | Замещённые фенилацетамиды и их применение в качестве активаторов глюкокиназы | |
EA200100826A1 (ru) | 16-галогенопроизводные эпотилона, способ их получения и их применение в фармацевтике | |
EA200500856A1 (ru) | Новые химические соединения | |
ATE357434T1 (de) | Disubstituierte thiazolylcarboxanilide und ihre verwendung als mikrobizide | |
CY1107985T1 (el) | Ccr1 ανταγωνιστες για την αγωγη μεταξυ αλλων απομυελινωτικης φλεγμονωδους νοσου | |
DE60318177D1 (de) | Rho-kinase inhibitoren | |
CY1105617T1 (el) | Νεα αρωματικα παραγωγα των φθορογλυκοσιδων, φαρμακα περιεχοντα αυτες τις ενωσεις και η χρηση τους | |
ATE543807T1 (de) | Verstärker von glutamat-rezeptoren | |
CY1113757T1 (el) | Παραγωγα πιπεριδινης και πιπεραζινης για τη θεραπεια ογκων | |
CY1105907T1 (el) | Νεα παραγωγα της 1,2,4 - θειαδιαζολης ως ρυθμιστες υποδοχεως μελανοκορτινης | |
BR0307432A (pt) | Difluormetiltiazolilcarboxanilidas | |
DK1480961T3 (da) | Glutaminylbaserede DPIV-inhibitorer | |
CY1107871T1 (el) | Παραγωγα πυριμιδινης και η χρηση τους ως ρυθμιστων cb2 | |
EA200301142A1 (ru) | Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6 | |
PA8571001A1 (es) | 2-(2,6-diclorofenil)-diarilimidazoles | |
DE60330407D1 (de) | Synthese von Epothilonen, Zwischenprodukte davon, Analoga und ihre Verwendung | |
LV12047A (lv) | Kondenseti pirimidina atvasinajumi un to lietosana par angiotenzina II antagonistiem | |
EA200001133A1 (ru) | Антипикорнавирусные композиции, их получение и применение | |
CY1109214T1 (el) | Μειγματα μυκητοκτονου που βασιζονται σε παραγωγα καρβαμικου και εντομοκτονα | |
CY1109964T1 (el) | Ετεροκυκλικοι δακτυλιοι συντηγμενοι με 1,4-διυδροπυριδινη, η διαδικασια παρασκευης τους, η χρηση και οι συνθεσεις που τους περιεχουν | |
CY1110537T1 (el) | Ενωσεις και μεθοδοι για την αγωγη της δυσλιπιδαιμιας |